Patents Assigned to Phloronol, Inc.
  • Patent number: 10106521
    Abstract: Provided herein are eckol derivatives, methods of synthesis thereof and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, Alzheimer's disease, microbial infections, obesity, diabetes, cancer or inflammation using the compounds and pharmaceutical compositions disclosed herein.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: October 23, 2018
    Assignee: Phloronol, Inc.
    Inventors: Hyeon-Cheol Shin, Hyejeong Hwang, Kwang Yong Park, Seong Ho Kim, Haengwoo Lee
  • Patent number: 10016471
    Abstract: Described herein are solid pharmaceutical compositions of brown algae extracts and methods for making solid pharmaceutical compositions of brown algae extracts. In some embodiments, the brown algae extract is derived from Ecklonia cava.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: July 10, 2018
    Assignee: Phloronol, Inc.
    Inventors: Hyeon-Cheol Shin, Hyejeong Hwang
  • Publication number: 20130196976
    Abstract: Disclosed are a composition for reducing beta amyloid-induced neurotoxicity by inhibiting ?-secretase activity, comprising a dibenzofuran derivative, and a method for preparing the same. Further disclosed is that the combination of the dibenzofuran derivative with a ?-secretase inhibitor or an anti-inflammatory agent shows higher activity with respect to reducing beta amyloid-induced neurotoxicity.
    Type: Application
    Filed: March 12, 2013
    Publication date: August 1, 2013
    Applicant: PHLORONOL, INC.
    Inventor: PHLORONOL, INC.
  • Publication number: 20120122822
    Abstract: Disclosed are a composition for reducing beta amyloid-induced neurotoxicity by inhibiting ?-secretase activity, comprising a dibenzofuran derivative, and a method for preparing the same. Further disclosed is that the combination of the dibenzofuran derivative with a ?-secretase inhibitor or an anti-inflammatory agent shows higher activity with respect to reducing beta amyloid-induced neurotoxicity.
    Type: Application
    Filed: November 17, 2010
    Publication date: May 17, 2012
    Applicant: Phloronol, Inc.
    Inventors: Bong-Ho LEE, Seongho KIM, Hyeon-Cheol SHIN, Haengwoo LEE